search
Back to results

Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant

Primary Purpose

Meniscus; Degeneration, Osteoarthritis, Knee

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
NUsurface Meniscus Implant
Sponsored by
Active Implants
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Meniscus; Degeneration focused on measuring NUsurface, Meniscus, Knee, KOOS

Eligibility Criteria

35 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Have a degenerative and/or torn meniscus and/or previous meniscectomy as confirmed by diagnostic MRI.
  2. Have a pain score of 75 or less on the KOOS pain scale, with 100 being normal.
  3. Be in neutral alignment +/- 5 degrees of the mechanical axis.
  4. Be between age 35 and 75 at the time of the planned surgery.
  5. Be able to be fitted anatomically with a size 30 to 90 NUsurface® device.
  6. Have a normal mental status.
  7. Be willing and able to attend all follow up visits, complete all study questionnaires, and undergo required X-ray and MRI schedule.
  8. Be able and willing to understand and sign the informed consent form.

Exclusion Criteria:

  1. Have evidence of a Grade IV articular cartilage loss on the medial tibial plateau or femoral condyle that could contact the NUsurface implant
  2. Have lateral compartment pain with lateral articular cartilage damage greater than Grade II (OB), and/or a lateral meniscus tear(s)
  3. Have a varus or valgus knee deformity > 5 degrees.
  4. Have a laxity level of more than II (ICRS), secondary to previous injury of the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial collateral ligament (MCL).
  5. Have patella instability or non-anatomically positioned patella
  6. Have patellar compartment pain and/or patellar articular cartilage damage greater than Grade II (OB).
  7. Need a tibial osteotomy at the time of surgery.
  8. Have an ACL reconstruction performed less than 9 months before implanting the NUsurface® device
  9. Have any type of previously implanted prosthetic meniscus or ligament or knee implant made of plastic.
  10. Have a knee flexion contracture > 10 degrees
  11. Be unable to flex the knee to 90 degrees
  12. Have a leg length discrepancy causing a noticeable limp.
  13. Have had a previous major knee condyle surgery
  14. Present with insufficiency fractures or avascular necrosis of the medial compartment.
  15. Have an active infection or tumor.
  16. Have any type of knee joint inflammatory disease including Sjogren's syndrome.
  17. Have neuropathic knee osteoarthropathy, also known as Charcot joint.
  18. Have any medical condition that does not allow arthroscopy at the point of entry to the knee.
  19. Be pregnant or is a female intending to become pregnant during the study period.
  20. Be mentally incapacitated.
  21. Be a prisoner.
  22. Be a patient who has economic incentive not to improve (e.g., workman's compensation patient)
  23. Be morbidly Obese (BMI > 35).
  24. Is unwilling or unable to have an X-ray, Fluro, or MRI of the affected knee

Sites / Locations

  • AZ Monica
  • Ghent University Hospital
  • Sporthopaedicum Berlin
  • UniKlinikum Regensburg
  • Emek Medical Center
  • Tel Aviv Sourasky Medical Center- Ichilov
  • Assaf Harofeh Medical Center
  • Sacro Cuore- Don Calabria Hospital
  • Maastricht University Medical Centre
  • Sahlgrenska universitetssjukhuset

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

NUsurface Meniscus Implant

Arm Description

Outcomes

Primary Outcome Measures

Knee injury and Osteoarthritis Outcome Score (KOOS)

Secondary Outcome Measures

Full Information

First Posted
October 18, 2012
Last Updated
April 4, 2023
Sponsor
Active Implants
search

1. Study Identification

Unique Protocol Identification Number
NCT01712191
Brief Title
Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant
Official Title
Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
January 2011 (Actual)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
March 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Active Implants

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a prospective, multi-center, open label, non-randomized study, evaluating the treating of medial meniscus deficiency with the NUsurface Meniscus Implant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Meniscus; Degeneration, Osteoarthritis, Knee
Keywords
NUsurface, Meniscus, Knee, KOOS

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
128 (Actual)

8. Arms, Groups, and Interventions

Arm Title
NUsurface Meniscus Implant
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
NUsurface Meniscus Implant
Primary Outcome Measure Information:
Title
Knee injury and Osteoarthritis Outcome Score (KOOS)
Time Frame
24 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Have a degenerative and/or torn meniscus and/or previous meniscectomy as confirmed by diagnostic MRI. Have a pain score of 75 or less on the KOOS pain scale, with 100 being normal. Be in neutral alignment +/- 5 degrees of the mechanical axis. Be between age 35 and 75 at the time of the planned surgery. Be able to be fitted anatomically with a size 30 to 90 NUsurface® device. Have a normal mental status. Be willing and able to attend all follow up visits, complete all study questionnaires, and undergo required X-ray and MRI schedule. Be able and willing to understand and sign the informed consent form. Exclusion Criteria: Have evidence of a Grade IV articular cartilage loss on the medial tibial plateau or femoral condyle that could contact the NUsurface implant Have lateral compartment pain with lateral articular cartilage damage greater than Grade II (OB), and/or a lateral meniscus tear(s) Have a varus or valgus knee deformity > 5 degrees. Have a laxity level of more than II (ICRS), secondary to previous injury of the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial collateral ligament (MCL). Have patella instability or non-anatomically positioned patella Have patellar compartment pain and/or patellar articular cartilage damage greater than Grade II (OB). Need a tibial osteotomy at the time of surgery. Have an ACL reconstruction performed less than 9 months before implanting the NUsurface® device Have any type of previously implanted prosthetic meniscus or ligament or knee implant made of plastic. Have a knee flexion contracture > 10 degrees Be unable to flex the knee to 90 degrees Have a leg length discrepancy causing a noticeable limp. Have had a previous major knee condyle surgery Present with insufficiency fractures or avascular necrosis of the medial compartment. Have an active infection or tumor. Have any type of knee joint inflammatory disease including Sjogren's syndrome. Have neuropathic knee osteoarthropathy, also known as Charcot joint. Have any medical condition that does not allow arthroscopy at the point of entry to the knee. Be pregnant or is a female intending to become pregnant during the study period. Be mentally incapacitated. Be a prisoner. Be a patient who has economic incentive not to improve (e.g., workman's compensation patient) Be morbidly Obese (BMI > 35). Is unwilling or unable to have an X-ray, Fluro, or MRI of the affected knee
Facility Information:
Facility Name
AZ Monica
City
Antwerpen
Country
Belgium
Facility Name
Ghent University Hospital
City
Ghent
Country
Belgium
Facility Name
Sporthopaedicum Berlin
City
Berlin
Country
Germany
Facility Name
UniKlinikum Regensburg
City
Regensburg
Country
Germany
Facility Name
Emek Medical Center
City
Afula
Country
Israel
Facility Name
Tel Aviv Sourasky Medical Center- Ichilov
City
Tel Aviv
ZIP/Postal Code
64239
Country
Israel
Facility Name
Assaf Harofeh Medical Center
City
Zerifin
Country
Israel
Facility Name
Sacro Cuore- Don Calabria Hospital
City
Negrar
Country
Italy
Facility Name
Maastricht University Medical Centre
City
Maastricht
Country
Netherlands
Facility Name
Sahlgrenska universitetssjukhuset
City
Göteborg
ZIP/Postal Code
41345
Country
Sweden

12. IPD Sharing Statement

Learn more about this trial

Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant

We'll reach out to this number within 24 hrs